Jutia Group The company's lead drug candidate, NeuVax (nelipepimut-S or E75), a cancer vaccine, is already in a phase 3 trial. It does ... EH: The company did not separate cohorts between the HER2-overexpressing and HER2 low- or intermediate -expressing patients. 更多 »
Community Impact Newspaper TLCC will seek a Good Manufacturing Practices certification for the building from the Food and Drug Administration, meaning it could be approved by the FDA to do pharmaceutical development. The building will be built by Georgetown Rail Equipment Co ...
Payvand Even if major pharmaceutical companies in the United States and European countries were able to obtain necessary permits from the US Treasury for trade with Iran, the intermediate banks would not accept to conduct transactions with Iran out of fear of ... 更多 »
Business Standard In a post-results interview, Pratip Chaudhuri, chairman and managing director, SBI, said that pharmaceutical companies are facing competition from rising imports since they have a serious cost disadvantage. Chaudhuri went on to add that the ... and more »
